New test may turn AZ's Lynparza into precision drug for prostate cancer

loading...


New test may turn AZ’s Lynparza into precision drug for prostate cancer
LONDON (Reuters) – Scientists have developed a new three-in-one blood test that has the potential to turn AstraZeneca’s drug Lynparza into a precision medicine for prostate cancer.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...